Logotype for VolitionRX Ltd

VolitionRX (VNRX) Proxy Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for VolitionRX Ltd

Proxy Filing summary

11 Feb, 2026

Executive summary

  • Special Meeting scheduled for March 31, 2026, to vote on two key proposals: issuing shares exceeding 20% of outstanding stock to Lind Global Asset Management XII LLC and authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-20, at the board's discretion.

  • Board unanimously recommends voting in favor of both proposals.

  • Record date for voting eligibility is February 9, 2026, with 135,565,326 shares outstanding.

  • Voting can be done online, by phone, mail, or in person, with results to be announced at the meeting and via SEC filings.

Voting matters and shareholder proposals

  • Proposal 1: Approve issuance of additional shares exceeding 20% of outstanding stock to Lind Global Asset Management XII LLC, in compliance with NYSE American Rule 713.

  • Proposal 2: Approve amendment to authorize a reverse stock split at a ratio between 1-for-5 and 1-for-20, at the board's discretion.

  • Both proposals require a majority vote of shares present or represented by proxy.

  • Abstentions count as votes against; broker non-votes have no effect.

Board of directors and corporate governance

  • Board of directors has full discretion to implement or abandon the reverse stock split even if approved by shareholders.

  • No director or executive officer has a substantial interest in the reverse stock split not shared by all shareholders.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more